Lymphangioleiomyomatosis: Searching for potential biomarkers
BackgroundVascular endothelial growth factor-D (VEGF-D) is the most commonly used biomarker for diagnosing lymphangioleiomyomatosis (LAM). However, lung biopsy is often necessary as well; therefore, defining new biomarkers for LAM is crucial. The aim of this study was to describe the diagnostic accu...
Glavni autori: | , , , , , , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Frontiers Media S.A.
2023-02-01
|
Serija: | Frontiers in Medicine |
Teme: | |
Online pristup: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1079317/full |